THERAPEUTIC CLASS

Lung cancer: current therapies and new targeted treatments

---

Lung cancer is the most frequent cause of cancer-related deaths worldwide. Every year, 1·8 million people are diagnosed
with lung cancer, and 1·6 million people die as a result of the disease. 5-year survival rates vary from 4–17% depending
on stage and regional diff erences. In this Seminar, we discuss existing treatment for patients with lung cancer and the
promise of precision medicine, with special emphasis on new targeted therapies. Some subgroups, eg—patients with
poor performance status and elderly patients—are not specifi cally addressed, because these groups require special
treatment considerations and no frameworks have been established in terms of new targeted therapies

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Oncology

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment